22Jan
Healthcare Antitrust – What to Expect in 2021
The year 2020 was an eventful one in the world of healthcare antitrust. The year began with the announcement of the precedent-setting settlement of the California Attorney General’s action against Sutter Health and ended with the settlement of multi-district antitrust litigation against the Blue Cross Blue Shield Association (and its member Blues)....
By:
Akerman LLP - Health Law Rx
Related
This month, New Jersey has expanded the state’s medical marijuana law and limited employers’ abili...
Read More >
In just its second Opinion Letter, OFCCP has [somewhat] tackled the issue of Pay Analysis Groups (PA...
Read More >
According to OPTIS Partners’ latest quarterly report, following a slowdown in the second quarter of...
Read More >
In recent years, there has been an ever-increasing number of public and private companies adopting e...
Read More >
In a welcomed attempt to align their approaches, the antitrust enforcers of the European Competition...
Read More >
In a stakeholder call yesterday, the CAISO discussed the Revised Draft Final Proposal in the Generat...
Read More >